Elizabeth G. Rhee, n/a

Merck & Co., Inc.
Rahway, New Jersey, United States

Disclosure(s): Merck & Co., Inc.: subsidiary and shareholder; Merck Sharp & Dohme LLC: employee

Presentation(s):

• 577 - Week 48 Results of a Phase 2 Study Evaluating Once-weekly Oral Islatravir Plus Lenacapavir

  Saturday, October 19, 2024
  2:09 PM – 2:21 PM US PT